InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

Current share price for CYP : $0.012 0.001 (7.69%)+

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Cleansing Notice 22 Aug 2025 9:18AM $0.210 $0.012 fallen by 94.29%
$3 Application for quotation of securities - CYP 22 Aug 2025 9:18AM $0.210 $0.012 fallen by 94.29%
$3 At-the-Market Subscription Agreement 22 Aug 2025 9:17AM $0.210 $0.012 fallen by 94.29%
$3 Cynata to present at Bioshares Biotech Summit 7 Aug 2025 8:46AM $0.175 $0.012 fallen by 93.14%
$3 Investor Webinar 5 Aug 2025 8:32AM $0.170 $0.012 fallen by 92.94%
$3 June 2025 Quarterly Activity Report and Appendix 4C 30 Jul 2025 9:45AM $0.175 $0.012 fallen by 93.14%
$3 Notification regarding unquoted securities - CYP 10 Jun 2025 3:57PM $0.175 $0.012 fallen by 93.14%
$3 Proposed issue of securities - CYP 4 Jun 2025 8:24AM $0.170 $0.012 fallen by 92.94%
$3 InvestorHub Portal and New Website 22 May 2025 8:43AM $0.200 $0.012 fallen by 94%
$3 CYP-001s FDA Approval Pathway Not Impeded 16 May 2025 12:12PM $0.190 $0.012 fallen by 93.68%
$3 Investor Webinar 5 May 2025 8:28AM $0.195 $0.012 fallen by 93.85%
$3 March 2025 Quarterly Activity Report and Appendix 4C 24 Apr 2025 1:12PM $0.195 $0.012 fallen by 93.85%
$3 Australian Federal Government Announces Funding of SMART CRC 24 Apr 2025 11:48AM $0.190 $0.012 fallen by 93.68%
$3 Cynata Establishes New Scientific Advisory Board 14 Apr 2025 8:45AM $0.190 $0.012 fallen by 93.68%
$3 Promising Preclinical Heart Disease Data 7 Apr 2025 8:46AM $0.165 $0.012 fallen by 92.73%
$3 Appendix 3Ys x 4 1 Apr 2025 6:00PM $0.205 $0.012 fallen by 94.15%
$3 Cynata Presenting at Advanced Therapies Congress 18 Mar 2025 8:50AM $0.213 $0.012 fallen by 94.35%
$3 Cynata Participating in Euroz Hartleys Investor Conference 12 Mar 2025 8:53AM $0.210 $0.012 fallen by 94.29%
$3 Appendix 4D & Half-Year Financial Statements 27 Feb 2025 3:04PM $0.255 $0.012 fallen by 95.29%
$3 Expiry of listed CYPOA Options 27 Feb 2025 11:58AM $0.255 $0.012 fallen by 95.29%
$3 Appendix 3Y - Paul Wotton 20 Feb 2025 3:22PM $0.240 $0.012 fallen by 95%
$3 Application for quotation of securities - CYP 20 Feb 2025 3:17PM $0.240 $0.012 fallen by 95%
$3 Investor Webinar 6 Feb 2025 8:56AM $0.245 $0.012 fallen by 95.10%
$3 Publication comparing Cymerus MSCs to other MSCs 5 Feb 2025 9:12AM $0.235 $0.012 fallen by 94.89%
$3 Cynata to Present at Euroz Hartleys Healthcare Forum 4 Feb 2025 8:37AM $0.228 $0.012 fallen by 94.73%

51 - 75 of 698 results

Page 3 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.